Item 9 Labs Corp.
INLB · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Revenue | $21,757 | $21,937 | $8,122 | $4,934 |
| % Growth | -0.8% | 170.1% | 64.6% | – |
| Cost of Goods Sold | $14,445 | $13,324 | $4,826 | $2,556 |
| Gross Profit | $7,312 | $8,613 | $3,296 | $2,378 |
| % Margin | 33.6% | 39.3% | 40.6% | 48.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $17,018 | $9,891 | $5,521 | $4,117 |
| SG&A Expenses | $18,830 | $11,062 | $5,786 | $4,859 |
| Sales & Mktg Exp. | $1,812 | $1,171 | $265 | $742 |
| Other Operating Expenses | $11,547 | $3,152 | $2,836 | $1,901 |
| Operating Expenses | $30,377 | $14,214 | $8,622 | $6,760 |
| Operating Income | -$23,065 | -$5,601 | -$5,326 | -$4,382 |
| % Margin | -106% | -25.5% | -65.6% | -88.8% |
| Other Income/Exp. Net | -$8,101 | -$5,305 | -$6,960 | $192 |
| Pre-Tax Income | -$31,166 | -$10,906 | -$12,386 | -$9,949 |
| Tax Expense | $13 | $0 | -$86 | $683 |
| Net Income | -$31,143 | -$10,906 | -$12,300 | -$10,631 |
| % Margin | -143.1% | -49.7% | -151.4% | -215.5% |
| EPS | -0.33 | -0.14 | -0.2 | -0.17 |
| % Growth | -135.7% | 30% | -17.6% | – |
| EPS Diluted | -0.33 | -0.14 | -0.2 | -0.17 |
| Weighted Avg Shares Out | 95,691 | 78,593 | 61,622 | 61,532 |
| Weighted Avg Shares Out Dil | 95,691 | 78,593 | 61,622 | 61,532 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $71 |
| Interest Expense | $6,415 | $5,295 | $6,960 | $343 |
| Depreciation & Amortization | $1,922 | $1,261 | $979 | $676 |
| EBITDA | -$22,829 | -$4,350 | -$4,447 | -$8,930 |
| % Margin | -104.9% | -19.8% | -54.8% | -181% |